Table 1.
Baseline characteristics of study population
| Characteristic | Total (n = 32) | Coinfection (n = 14) | Noncoinfection (n = 18) | P* |
|---|---|---|---|---|
| Age, y | 52 (41,65) | 57 (47,69) | 48 (38,59) | .367 |
| Male sex no.(%) | 20 (62.5%) | 11 (78.6%) | 9 (50.0%) | .098 |
| ICU admission | 13 (40%) | 11 (78.6%) | 2 (11.1%) | <.001 |
| Symptom | ||||
| Fever | 22 (68.8%) | 10 (71.4%) | 12 (66.7%) | 1.000 |
| cough | 23 (71.9%) | 9 (64.3%) | 14 (77.8%) | .453 |
| Expectoration | 19 (59.4%) | 8 (57.1%) | 11 (61.1%) | 1.000 |
| Thoracalgia | 1 (3.1%) | 0 | 1 (5.6%) | |
| Rhinobyon/pharyngalgia | 4 (12.5%) | 1 (7.1%) | 3 (16.7%) | |
| Headache | 1 (3.1%) | 0 | 1 (5.6%) | |
| Dyspnea | 12 (37.5%) | 8 (57.1%) | 4 (22.2%) | .068 |
| Breathlessness | 9 (28.1%) | 7 (50.0%) | 2 (11.1%) | .022 |
| Myalgia | 7 (21.9%) | 3 (21.4%) | 4 (22.2%) | 1.000 |
| Fatigue | 7 (21.9%) | 3 (31.4%) | 4 (22.2%) | 1.000 |
| Diarrhea | 3 (9.4%) | 2 (14.3%) | 1 (5.6%) | |
| Conscious disturbance | 3 (9.4%) | 2 (14.3%) | 1 (5.6%) | |
| Complication | ||||
| ARDS | 10 (31.3%) | 9 (64.3%) | 1 (5.6%) | .001 |
| Shock | 5 (15.6%) | 5 (35.7%) | 0 | .012 |
| Acute renal injury | 6 (18.8%) | 5 (35.7%) | 1 (5.6%) | .064 |
| Radiographic findings | ||||
| GGO only | 11 (34.4%) | 3 (21.4%) | 8 (44.4%) | .025 |
| GGO + consolidation | 17 (53%) | 11 (78.6%) | 6 (33.3%) | |
| Consolidation | 4 (12.5%) | 0 | 4 (22.2%) | |
| Respiratory support | ||||
| No need | 7 (21.9%) | 1 (7.1%) | 6 (33.3%) | .003 |
| Nasal catheter oxygen | 12 (37.5%) | 2 (14.3%) | 10 (55.6%) | |
| Noninvasive ventilation | 3 (9.4%) | 3 (21.4%) | 0 | |
| Invasive ventilation | 6 (18.8%) | 4 (28.6%) | 2 (11.1%) | |
| ECMO | 4 (12.5%) | 4 (28.6%) | 0 |
Abbreviations: ARDS, acute respiratory distress syndrome; ECMO, extracorporeal membrane oxygenation; GGO, ground‐glass opacity; ICU, intensive care unit.
*Comparison of clinical characteristics between patients with COVID‐19 with and without coinfection.